vs
GAIA, INC（GAIA）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是GAIA, INC的1.4倍（$35.5M vs $25.5M），GAIA, INC净利率更高（-0.3% vs -304.2%，领先303.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 5.8%），GAIA, INC自由现金流更多（$76.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 9.4%）
Gaia Inc.是一家美国媒体公司，1988年由伊尔卡·里萨维在科罗拉多州路易斯维尔创立，在纳斯达克上市，股票代码GAIA。该公司运营订阅视频点播平台Gaia TV，提供原创和授权的另类媒体纪录片，内容涵盖健康、灵性等主题。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GAIA vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.4倍
$25.5M
营收增速更快
RXRX
高出675.9%
5.8%
净利率更高
GAIA
高出303.9%
-304.2%
自由现金流更多
GAIA
多$47.4M
$-47.3M
两年增速更快
RXRX
近两年复合增速
9.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $25.5M | $35.5M |
| 净利润 | $-75.0K | $-108.1M |
| 毛利率 | 87.6% | 59.8% |
| 营业利润率 | -2.6% | -304.8% |
| 净利率 | -0.3% | -304.2% |
| 营收同比 | 5.8% | 681.7% |
| 净利润同比 | 91.7% | 39.6% |
| 每股收益（稀释后） | $-0.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GAIARXRX
| Q4 25 | $25.5M | $35.5M | ||
| Q3 25 | $25.0M | $5.2M | ||
| Q2 25 | $24.6M | $19.2M | ||
| Q1 25 | $23.8M | $14.7M | ||
| Q4 24 | $24.1M | $4.5M | ||
| Q3 24 | $22.0M | $26.1M | ||
| Q2 24 | $21.9M | $14.4M | ||
| Q1 24 | $21.3M | $13.8M |
净利润GAIARXRX
| Q4 25 | $-75.0K | $-108.1M | ||
| Q3 25 | $-1.2M | $-162.3M | ||
| Q2 25 | $-2.0M | $-171.9M | ||
| Q1 25 | $-1.2M | $-202.5M | ||
| Q4 24 | $-907.0K | $-178.9M | ||
| Q3 24 | $-1.2M | $-95.8M | ||
| Q2 24 | $-2.2M | $-97.5M | ||
| Q1 24 | $-971.0K | $-91.4M |
毛利率GAIARXRX
| Q4 25 | 87.6% | 59.8% | ||
| Q3 25 | 86.4% | -183.8% | ||
| Q2 25 | 86.7% | -4.9% | ||
| Q1 25 | 87.7% | -48.0% | ||
| Q4 24 | 88.2% | -181.4% | ||
| Q3 24 | 86.1% | 53.7% | ||
| Q2 24 | 84.5% | 36.2% | ||
| Q1 24 | 85.3% | 19.1% |
营业利润率GAIARXRX
| Q4 25 | -2.6% | -304.8% | ||
| Q3 25 | -5.0% | -3327.6% | ||
| Q2 25 | -8.9% | -916.8% | ||
| Q1 25 | -4.3% | -1297.9% | ||
| Q4 24 | -7.1% | -4042.4% | ||
| Q3 24 | -5.3% | -377.1% | ||
| Q2 24 | -9.1% | -697.4% | ||
| Q1 24 | -4.0% | -698.4% |
净利率GAIARXRX
| Q4 25 | -0.3% | -304.2% | ||
| Q3 25 | -4.6% | -3135.3% | ||
| Q2 25 | -8.3% | -894.2% | ||
| Q1 25 | -5.1% | -1373.3% | ||
| Q4 24 | -3.8% | -3935.5% | ||
| Q3 24 | -5.4% | -367.5% | ||
| Q2 24 | -9.9% | -676.6% | ||
| Q1 24 | -4.6% | -662.4% |
每股收益（稀释后）GAIARXRX
| Q4 25 | $-0.02 | $-0.17 | ||
| Q3 25 | $-0.05 | $-0.36 | ||
| Q2 25 | $-0.07 | $-0.41 | ||
| Q1 25 | $-0.04 | $-0.50 | ||
| Q4 24 | $-0.03 | $-0.56 | ||
| Q3 24 | $-0.05 | $-0.34 | ||
| Q2 24 | $-0.09 | $-0.40 | ||
| Q1 24 | $-0.05 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.5M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $87.9M | $1.1B |
| 总资产 | $154.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资GAIARXRX
| Q4 25 | $13.5M | $743.3M | ||
| Q3 25 | $14.2M | $659.8M | ||
| Q2 25 | $13.9M | $525.1M | ||
| Q1 25 | $13.1M | $500.5M | ||
| Q4 24 | $5.9M | $594.4M | ||
| Q3 24 | $4.4M | $427.6M | ||
| Q2 24 | $5.5M | $474.3M | ||
| Q1 24 | $8.6M | $296.3M |
总债务GAIARXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益GAIARXRX
| Q4 25 | $87.9M | $1.1B | ||
| Q3 25 | $86.3M | $1.0B | ||
| Q2 25 | $85.7M | $919.1M | ||
| Q1 25 | $87.0M | $933.9M | ||
| Q4 24 | $80.7M | $1.0B | ||
| Q3 24 | $81.2M | $524.6M | ||
| Q2 24 | $82.1M | $584.4M | ||
| Q1 24 | $84.8M | $401.2M |
总资产GAIARXRX
| Q4 25 | $154.6M | $1.5B | ||
| Q3 25 | $151.1M | $1.4B | ||
| Q2 25 | $147.0M | $1.3B | ||
| Q1 25 | $148.5M | $1.3B | ||
| Q4 24 | $141.2M | $1.4B | ||
| Q3 24 | $139.6M | $726.5M | ||
| Q2 24 | $142.1M | $775.9M | ||
| Q1 24 | $133.8M | $557.8M |
负债/权益比GAIARXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $76.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | 0.3% | -133.1% |
| 资本支出强度资本支出/营收 | 6.6% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-377.0K | $-378.3M |
8季度趋势，按日历期对齐
经营现金流GAIARXRX
| Q4 25 | $1.8M | $-46.1M | ||
| Q3 25 | $326.0K | $-117.4M | ||
| Q2 25 | $2.3M | $-76.4M | ||
| Q1 25 | $1.3M | $-132.0M | ||
| Q4 24 | $2.7M | $-115.4M | ||
| Q3 24 | $409.0K | $-59.2M | ||
| Q2 24 | $-2.1M | $-82.2M | ||
| Q1 24 | $5.9M | $-102.3M |
自由现金流GAIARXRX
| Q4 25 | $76.0K | $-47.3M | ||
| Q3 25 | $-1.6M | $-117.6M | ||
| Q2 25 | $880.0K | $-79.6M | ||
| Q1 25 | $268.0K | $-133.8M | ||
| Q4 24 | $1.6M | $-116.7M | ||
| Q3 24 | $-952.0K | $-63.8M | ||
| Q2 24 | $-3.5M | $-83.4M | ||
| Q1 24 | $4.9M | $-109.0M |
自由现金流率GAIARXRX
| Q4 25 | 0.3% | -133.1% | ||
| Q3 25 | -6.4% | -2272.5% | ||
| Q2 25 | 3.6% | -413.9% | ||
| Q1 25 | 1.1% | -907.4% | ||
| Q4 24 | 6.5% | -2567.7% | ||
| Q3 24 | -4.3% | -244.6% | ||
| Q2 24 | -16.1% | -578.5% | ||
| Q1 24 | 22.8% | -789.9% |
资本支出强度GAIARXRX
| Q4 25 | 6.6% | 3.5% | ||
| Q3 25 | 7.7% | 4.7% | ||
| Q2 25 | 5.7% | 16.4% | ||
| Q1 25 | 4.3% | 12.4% | ||
| Q4 24 | 4.6% | 28.6% | ||
| Q3 24 | 6.2% | 17.5% | ||
| Q2 24 | 6.6% | 8.2% | ||
| Q1 24 | 5.0% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
RXRX
暂无分部数据
